Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Elan Shareholder Vote Indicates Lack Of Faith In Management’s Decisions

17 Jun 2013

• By Lisa LaMotta

Related Content

Elan’s Martin Aims To Set The Record Straight About Recent Buying Spree

07 Jun 2013

Elan Prepares For A Buying Spree Now That Biogen Has Taken Over Tysabri

06 Feb 2013

GSK’s <em>Breo Ellipta</em> Approved With COPD Airflow Obstruction, Exacerbation Claims

10 May 2013

Elan Makes A $1 Billion Theravance Royalty Play; What Will Investors Say?

13 May 2013

Related Companies

Elan Corporation

Royalty Pharma plc

Biogen, Inc.

Innoviva, Inc.

GSK plc

AOP Orphan Pharmaceuticals AG

Perrigo Company PLC

Additional Topics

Business Strategies Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.